India, Aug. 22 -- To revolutionise biomedical and clinical diagnostics research, the Indian Institute of Technology Delhi (IIT Delhi) has inaugurated a Biosafety Level 3 (BSL3) facility as part of its Central Research Facility (CRF).

The new facility will facilitate research on diagnostic devices and therapeutics for class-3 pathogens, marking the first such initiative among leading educational institutions in India.

This landmark achievement represents a major stride in India's biomedical research capabilities and reaffirms IIT Delhi's commitment to driving innovation in healthcare technology.

"This new research and testing facility will enable research and innovation in medical diagnostics and therapeutics and support IIT Delhi's eff...